{"id":"7ac10a0a-ecef-53bd-9e7c-5c381969ac96","stable_key":"6612c190-1948-5bcf-bbe3-a7f6c50fa3cf:l-proline-eprs-stress-rescue","predicate":"reverses","statement":"Exogenous proline reversed halofuginone-induced amino-acid response signaling and selected cellular effects in the study, consistent with competition at the prolyl-tRNA synthetase step.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"77ff54fb-ba8c-5faa-9862-a9d2d0ee5cc9","mechanism_event_label":"Restoring access to a blocked loading step can turn off a shortage-like signal.","subject":{"id":"70ccd53c-83ad-5251-a4f5-6370973bc40a","slug":"l-proline","display_name":"L-Proline","entity_type_key":"small_molecule"},"object":{"id":"0e3c9b7b-9dd0-57a2-9cbf-d9d0e25fd3aa","slug":"mouse-halofuginone-amino-acid-response","display_name":"Mouse-cell amino acid response during halofuginone exposure","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"77ff54fb-ba8c-5faa-9862-a9d2d0ee5cc9","stable_key":"6612c190-1948-5bcf-bbe3-a7f6c50fa3cf:l-proline-eprs-stress-rescue-event","event_type":"observed_relationship","label":"Restoring access to a blocked loading step can turn off a shortage-like signal.","description":"Exogenous proline reversed halofuginone-induced amino-acid response signaling and selected cellular effects in the study, consistent with competition at the prolyl-tRNA synthetase step.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"70ccd53c-83ad-5251-a4f5-6370973bc40a","slug":"l-proline","display_name":"L-Proline","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"0e3c9b7b-9dd0-57a2-9cbf-d9d0e25fd3aa","slug":"mouse-halofuginone-amino-acid-response","display_name":"Mouse-cell amino acid response during halofuginone exposure","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"65134803-3a5b-59ed-a593-5cea114ab988","slug":"halofuginone","display_name":"Halofuginone","entity_type_key":"drug"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"3876a24a-f6fe-5900-8ce2-22525a4faacb","slug":"mouse-eif2ak4","display_name":"Mouse GCN2 / Eif2ak4","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"fc8e1dad-14a4-5aa0-856a-d63340fa3187","slug":"mouse-eif2s1","display_name":"Mouse eIF2α / Eif2s1","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary full text","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Mouse embryonic fibroblast and immune-cell experiments with halofuginone; model and assay-specific concentrations.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Not every proline-processing defect is competitively reversible, and this is not a clinical drug-interaction dose recommendation.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"l-proline","display_name":"L-Proline","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Restoring access to a blocked loading step can turn off a shortage-like signal.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22327401/ · DOI 10.1038/nchembio.790","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"337e0c0e-6c4f-5f62-a11d-5984e76dbb00","evidence_kind":"source_excerpt","locator":"Lines 238-244","start_line":238,"end_line":244,"excerpt":"## l-proline-eprs-stress-rescue\nRestoring access to a blocked loading step can turn off a shortage-like signal.\nExogenous proline reversed halofuginone-induced amino-acid response signaling and selected cellular effects in the study, consistent with competition at the prolyl-tRNA synthetase step.\nModel: Mouse embryonic fibroblast and immune-cell experiments with halofuginone; model and assay-specific concentrations.\nLimitations: Not every proline-processing defect is competitively reversible, and this is not a clinical drug-interaction dose recommendation.\nEvidence access: Primary full text\nHalofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22327401/ · DOI 10.1038/nchembio.790","model_system":"Mouse embryonic fibroblast and immune-cell experiments with halofuginone; model and assay-specific concentrations.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"e5aa7fc5-ee52-5376-8169-416082a89fd1","stable_key":"import-6612c190-1948-5bcf-bbe3-a7f6c50fa3cf","title":"L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"7b7f1981f9c7897fbb6baa19425bdc19dede78ad4d66fa554394b8337c7366fb","revision_id":"4971a925-fa70-59f8-8030-d3029a18a62f","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}